Fluxametamide Patent Landscape Analysis

Fluxametamide is an isoxazoline insecticide developed by Nissan Chemical, commercialised through the GRACIA® brand.

The retained landscape covers 60 patent families across 25 consolidated owner groups. Two-active combination is the thickest protection layer (40 families), with manufacturing route and intermediates providing additional constraint.

Forty-seven of the 60 retained families carry a grant or national pending reading. Eleven families are held by China-based applicants; seven live families have a nominal term ending within five years. Position as at October 2026.

This 41-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.